Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets
about
Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@en
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@nl
type
label
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@en
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@nl
prefLabel
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@en
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@nl
P2093
P921
P1476
Carbamylated monomeric allergo ...... treatment using Lais® tablets
@en
P2093
P577
2010-10-01T00:00:00Z